CNSP stock news
This page provides real-time market news, earnings updates, and company announcements related to CNS Pharmaceuticals, Inc. (CNSP).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-19 08:51 EST
SoftBank and Nvidia are said to be negotiating an investment in Skild AI at a $14 billion valuation, which would almost triple the company's worth
Bitget-RWA2025-12-09 03:09:24
What Can Investors Anticipate From Cohen & Steers’s (CNS) Fourth Quarter Earnings
101 finance2026-01-21 03:15:29
Cohen & Steers (NYSE:CNS) Reports Fourth Quarter 2025 Revenue Matching Projections
101 finance2026-01-22 21:54:12
CNS Q4 Analysis: Margin Pressure Diminishes Impact of Net Inflows and Product Growth
101 finance2026-01-26 18:12:38
5 Essential Analyst Inquiries from Cohen & Steers’s Fourth Quarter Earnings Call
101 finance2026-01-29 08:33:33
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
Finviz2026-02-12 21:39:08
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Finviz2026-02-17 12:03:44
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Finviz2026-02-17 12:33:43
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Finviz2026-02-17 12:33:43
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
Cellectar Biosciences Expands Global Intellectual Property Estate
Finviz2026-02-17 13:09:11
5 Thought-Provoking Analyst Inquiries From Royalty Pharma’s Fourth Quarter Earnings Discussion
101 finance2026-02-18 09:54:32
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-18 12:03:22
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
Finviz2026-02-18 13:33:36
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals
Finviz2026-02-19 13:03:13
Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals
Finviz2026-02-19 13:03:13
Cassava Announces Closure of U.S. Department of Justice Investigation
Finviz2026-02-19 13:06:40
5 Essential Analyst Inquiries from Cohen & Steers’s Fourth Quarter Earnings Call
101 finance2026-01-29 08:33:33
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
Finviz2026-02-12 21:39:08
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Finviz2026-02-17 12:03:44
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Finviz2026-02-17 12:33:43
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
Finviz2026-02-17 12:33:43
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
Cellectar Biosciences Expands Global Intellectual Property Estate
Finviz2026-02-17 13:09:11
5 Thought-Provoking Analyst Inquiries From Royalty Pharma’s Fourth Quarter Earnings Discussion
101 finance2026-02-18 09:54:32
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-18 12:03:22
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
Finviz2026-02-18 13:33:36
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals
Finviz2026-02-19 13:03:13
Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals
Finviz2026-02-19 13:03:13
Cassava Announces Closure of U.S. Department of Justice Investigation
Finviz2026-02-19 13:06:40
CNSP stock chart
CNSP stock detailsCNSP stock price change
On the last trading day, CNSP stock closed at 3.46 USD, with a price change of -6.49% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more